§ BIOTECHNOLOGY
USD · BiotechnologyORIC
ORIC PHARMACEUTICALS INC
USDSector · BiotechnologyBeta · 1.14
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
116 increased/new, 45 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 2.07 | EPS (TTM) | -1.35 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Nextech Invest Ltd. | 7.2M | 6.4% | ±0% |
| EcoR1 Capital, LLC | 6.7M | 3.6% | ±0% |
| BlackRock, Inc. | 6.0M | 0.0% | +2% |
| Viking Global | 5.8M | 0.2% | −11% |
| SR One Capital Management, LP | 4.5M | 6.4% | ±0% |
| Pfizer Inc | 4.8M | 24.1% | −11% |
◇ AC INTELLIGENCE
Top institutional owners for ORIC as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER93.6% · 125 holders
DEALER / BANK9.5% · 16 holders
TACTICAL / MACRO8.8% · 6 holders
PASSIVE / INDEX8.7% · 9 holders
QUALITY / COMPOUNDER6.5% · 11 holders
INCOME / DEFENSIVE0.4% · 10 holders
GROWTH / MOMENTUM0.1% · 1 holder
ACTIVIST0.0% · 1 holder
SYSTEMATIC / QUANT0.0% · 3 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for ORIC in the last 180 days.